Cargando…

Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity

Infiltration of regulatory T cells (Tregs) in the tumor microenvironment suppresses anti-tumor immune response, and promotes tumor progression. Tumor necrosis factor receptor‐2 (TNFR2), which is highly expressed on Tregs, activates Tregs through nuclear factor kappa B (NF-κB) pathway. Moreover, TNFR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yonglin, Jia, Manxue, Wang, Sharon, Xu, Sherry, He, Nanhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889907/ https://www.ncbi.nlm.nih.gov/pubmed/35251028 http://dx.doi.org/10.3389/fimmu.2022.835690

Ejemplares similares

Targeted killing of TNFR2-expressing tumor cells and T(regs) by TNFR2 antagonistic antibodies in advanced Sézary syndrome
por: Torrey, H, et al.
Publicado: (2018)

The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
por: Richter, Fabian, et al.
Publicado: (2021)

TNFR2 Costimulation Differentially Impacts Regulatory and Conventional CD4(+) T-Cell Metabolism
por: Mensink, Mark, et al.
Publicado: (2022)

Targeting TNFR2 in Cancer: All Roads Lead to Rome
por: Bai, Jingchao, et al.
Publicado: (2022)

MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2
por: Jiang, Mengmeng, et al.
Publicado: (2022)

Distinct Role of TNFR1 and TNFR2 in Protective Immunity Against Orientia tsutsugamushi Infection in Mice
por: Liang, Yuejin, et al.
Publicado: (2022)

TARGETING TREG CELLS BY TNFR2 ANTIBODY INDUCES TUMOR REGRESSION IN VIVO
por: Yi, Zuoan David, et al.
Publicado: (2023)

Alleviation of Ultraviolet-B Radiation-Induced Photoaging by a TNFR Antagonistic Peptide, TNFR2-SKE
por: Lee, Kyoung-Jin, et al.
Publicado: (2019)

The effects of TNF‐α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer
por: Qu, Yang, et al.
Publicado: (2021)

Early Pro-Inflammatory Signal and T-Cell Activation Associate With Vaccine-Induced Anti-Vaccinia Protective Neutralizing Antibodies
por: Hou, Jue, et al.
Publicado: (2021)

Therapeutic potential of TNFR2 agonists: a mechanistic perspective
por: Chen, Yibo, et al.
Publicado: (2023)

Brazilian green propolis promotes TNFR2 expression on regulatory T cells
por: Mikami, Norihisa, et al.
Publicado: (2021)

The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
por: Takahashi, Hiroyuki, et al.
Publicado: (2022)

Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation
por: Schmid, Tobias, et al.
Publicado: (2017)

TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments
por: Liao, Ping, et al.
Publicado: (2023)

MicroRNA-4443 Causes CD4+ T Cells Dysfunction by Targeting TNFR-Associated Factor 4 in Graves’ Disease
por: Qi, Yicheng, et al.
Publicado: (2017)

Tumor Necrosis Factor Induces Tumor Promoting and Anti-Tumoral Effects on Pancreatic Cancer via TNFR1
por: Chopra, Martin, et al.
Publicado: (2013)

A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity
por: Vargas, Juan Gamboa, et al.
Publicado: (2022)

Tregalizumab – A Monoclonal Antibody to Target Regulatory T Cells
por: König, Martin, et al.
Publicado: (2016)

Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F–induced disease
por: Müller, Peter, et al.
Publicado: (2021)

The Key Role of TNF-TNFR2 Interactions in the Modulation of Allergic Inflammation: A Review
por: Ahmad, Suhana, et al.
Publicado: (2018)

Editorial: The Role of TNF-TNFR2 Signal in Immunosuppressive Cells and Its Therapeutic Implications
por: Chen, Xin, et al.
Publicado: (2019)

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS
por: Pegoretti, Valentina, et al.
Publicado: (2023)

A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
por: Cui, Xiaopei, et al.
Publicado: (2021)

Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules
por: So, Takanori, et al.
Publicado: (2013)

The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response
por: Moatti, Audrey, et al.
Publicado: (2021)

Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists
por: Vaisman-Mentesh, Anna, et al.
Publicado: (2019)

Editorial: The role of TNF-TNFR2 signal in immunosuppressive cells and its therapeutic implications, volume II
por: Chen, Xin, et al.
Publicado: (2023)

Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
por: McRitchie, Bayley R., et al.
Publicado: (2022)

Targeting Malignant Brain Tumors with Antibodies
por: Razpotnik, Rok, et al.
Publicado: (2017)

Targeting regulatory T cells by E7777 enhances CD8 T-cell–mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models
por: Mahdi, Haider S., et al.
Publicado: (2023)

Improvement of the sepsis survival rate by adenosine 2a receptor antagonists depends on immune regulatory functions of regulatory T-cells
por: Zhang, Teng, et al.
Publicado: (2022)

Oxidative Stress Promotes Instability of Regulatory T Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Shimojima, Yasuhiro, et al.
Publicado: (2021)

A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies
por: Li, Fubin, et al.
Publicado: (2012)

Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by reducing signaling activity through epitope selection
por: Akiba, Hiroki, et al.
Publicado: (2023)

Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab
por: Kowalczyk-Quintas, Christine, et al.
Publicado: (2018)

A 8-mer Peptide of PGLYRP1/Tag7 Innate Immunity Protein Binds to TNFR1 Receptor and Inhibits TNFα-Induced Cytotoxic Effect and Inflammation
por: Telegin, Georgii B., et al.
Publicado: (2021)

Antibody Targeting of “Steady-State” Dendritic Cells Induces Tolerance Mediated by Regulatory T Cells
por: Mahnke, Karsten, et al.
Publicado: (2016)

Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013)

Editorial: Targeting TNF/TNFR signaling pathways
por: Pan, Liqiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_avdt4p2f5pmb1ngldud68elj4n